Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 4/20 | 0.43 |
| ▸ | RAB9A | P51151 | 4/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29174999 | 0.91 | HTR2C (0.47) | HTR2CKMT2AMEN1NPSR1NPC1 | |
| SCHEMBL15000800 | 0.87 | HTR2C (0.50) | HTR2CKMT2AMEN1NPSR1NPC1 | |
| SCHEMBL31084552 | 0.83 | HTR2C (0.48) | HTR2CKMT2AMEN1NPSR1NPC1 | |
| SCHEMBL630773 | 0.83 | MEN1 (0.49) | HTR2CKMT2AMEN1NPSR1NPC1 | |
| SCHEMBL7245273 | 0.83 | MEN1 (0.49) | HTR2CKMT2AMEN1NPSR1NPC1 | |
| SCHEMBL29174956 | 0.82 | HTR2C (0.42) | HTR2C | |
| SCHEMBL27254036 | 0.82 | HTR2C (0.47) | HTR2CKMT2AMEN1NPSR1NPC1 | |
| Trifluoroacetic Acid SCHEMBL15019736 | 0.81 | HTR2C (0.44) | HTR2CKMT2AMEN1NPSR1NPC1 | |
| Pyridine SCHEMBL28216266 | 0.81 | HTR2C (0.44) | HTR2CKMT2AMEN1NPSR1NPC1 | |
| Hydrochloric Acid SCHEMBL26983226 | 0.81 | HTR2C (0.46) | HTR2CKMT2AMEN1NPSR1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117430633-A | Small molecular compound for treating ischemic stroke and preparation method and application thereof | 上海市第六人民医院 | 2024-01-23 | — | — | CN | claimed |
| US-20250120988-A1 | SMALL MOLECULE COMPOUND FOR TREATING ISCHEMIC STROKE, ITS PREPARATION METHOD, AND APPLICATION | SHANGHAI SIXTH PEOPLE'S HOSPITAL (CN) | 2025-04-17 | — | — | US | disclosed |
| CN-117430633-A | Small molecular compound for treating ischemic stroke and preparation method and application thereof | 上海市第六人民医院 | 2024-01-23 | — | — | CN | disclosed |
| EP-2607362-B1 | Piperidine and piperazine carboxylates as FAAH inhibitors | ASTELLAS PHARMA INC (JP) | 2014-12-31 | — | — | EP | disclosed |
| EP-1849773-B1 | Piperazine derivatives for the treatment of urinary incontinence and pain | ASTELLAS PHARMA INC (JP) | 2013-10-16 | — | — | EP | disclosed |
| EP-2607362-A1 | Piperidine and piperazine carboxylates as FAAH inhibitors | Astellas Pharma Inc. (JP) | 2013-06-26 | — | — | EP | disclosed |
| US-7919494-B2 | Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate compound | ASTELLAS PHARMA, INC. (JP) | 2011-04-05 | — | — | US | disclosed |
| US-7919495-B2 | Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate compound | ASTELLAS PHARMA, INC. (JP) | 2011-04-05 | — | — | US | disclosed |
| US-7915261-B2 | Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate compound | ASTELLAS PHARMA, INC. (JP) | 2011-03-29 | — | — | US | disclosed |
| US-20100009972-A1 | Pyridyl Non-Aromatic Nitrogen-Containing Heterocyclic-1-Carboxylate Compound | ASTELLAS PHARMA INC. (JP) | 2010-01-14 | — | — | US | disclosed |
| US-20100009971-A1 | Pyridyl Non-Aromatic Nitrogen-Containing Heterocyclic-1-Carboxylate Compound | ASTELLAS PHARMA INC. (JP) | 2010-01-14 | — | — | US | disclosed |
| US-20080306046-A1 | Pyridyl Non-Aromatic Nitrogen-Containing Heterocyclic-1-Carboxylate Derivative | FMC CORPORATION (US) | 2008-12-11 | — | — | US | disclosed |
| EP-1849773-A1 | PYRIDYL NON-AROMATIC NITROGENATED HETEROCYCLIC-1-CARBOXYLATE ESTER DERIVATIVE | Astellas Pharma Inc. (JP) | 2007-10-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250120988-A1 | SMALL MOLECULE COMPOUND FOR TREATING ISCHEMIC STROKE, ITS PREPARATION METHOD, AND APPLICATION | GRIN2B, GRIN2A, GRIN2C | HTR2C 273/4885KMT2A 666/4885MEN1 3915/4885 |
| US-20080306046-A1 | Pyridyl Non-Aromatic Nitrogen-Containing Heterocyclic-1-Carboxylate Derivative | FAAH, FAAH2, APEH | HTR2C 1125/4885KMT2A 2467/4885MEN1 4843/4885 |
| US-20100009972-A1 | Pyridyl Non-Aromatic Nitrogen-Containing Heterocyclic-1-Carboxylate Compound | FAAH, FAAH2, CNR2 | HTR2C 446/4885KMT2A 2469/4885MEN1 4731/4885 |
| US-20100009971-A1 | Pyridyl Non-Aromatic Nitrogen-Containing Heterocyclic-1-Carboxylate Compound | FAAH, FAAH2, CNR1 | HTR2C 467/4885KMT2A 2502/4885MEN1 4727/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.